Cargando…

Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder

BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to est...

Descripción completa

Detalles Bibliográficos
Autores principales: Rappaport, Lance M., Hunter, Michael D., Russell, Jennifer J., Pinard, Gilbert, Bleau, Pierre, Moskowitz, D.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Joule Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955850/
https://www.ncbi.nlm.nih.gov/pubmed/33026311
http://dx.doi.org/10.1503/jpn.190164
_version_ 1783664327401668608
author Rappaport, Lance M.
Hunter, Michael D.
Russell, Jennifer J.
Pinard, Gilbert
Bleau, Pierre
Moskowitz, D.S.
author_facet Rappaport, Lance M.
Hunter, Michael D.
Russell, Jennifer J.
Pinard, Gilbert
Bleau, Pierre
Moskowitz, D.S.
author_sort Rappaport, Lance M.
collection PubMed
description BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to establish whether, during community psychopharmacological treatment of social anxiety disorder, changes in positive or negative affect and agreeable or quarrelsome behaviour mediate improvement in social anxiety symptom severity or follow from it. METHODS: Adults diagnosed with social anxiety disorder (n = 48) recorded their interpersonal behaviour and affect naturalistically in an event-contingent recording procedure for 1-week periods before and during the first 4 months of treatment with paroxetine. Participants and treating psychiatrists assessed the severity of social anxiety symptoms monthly. A multivariate latent change score framework examined temporally lagged associations of change in affect and interpersonal behaviour with change in social anxiety symptom severity. RESULTS: Elevated agreeable behaviour and positive affect predicted greater subsequent reduction in social anxiety symptom severity over the following month of treatment. Elevated negative affect, but not quarrelsome behaviour, predicted less subsequent reduction in symptom severity. LIMITATIONS: Limitations included limited assessment of extreme behaviour (e.g., violence) that may have precluded examining the efficacy of paroxetine because of the lack of a placebo control group. CONCLUSION: The present study suggests that interpersonal behaviour and affect may be putative mechanisms of action for serotonergic treatment of social anxiety disorder. Prosocial behaviour and positive affect increase during serotonergic treatment of social anxiety disorder. Specifically, modulating agreeable behaviour, positive affect and negative affect in individuals’ daily lives may partially explain and refine clinical intervention.
format Online
Article
Text
id pubmed-7955850
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Joule Inc.
record_format MEDLINE/PubMed
spelling pubmed-79558502021-03-19 Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder Rappaport, Lance M. Hunter, Michael D. Russell, Jennifer J. Pinard, Gilbert Bleau, Pierre Moskowitz, D.S. J Psychiatry Neurosci Research Paper BACKGROUND: Affective and interpersonal behavioural patterns characteristic of social anxiety disorder show improvement during treatment with serotonin agonists (e.g., selective serotonin reuptake inhibitors), commonly used in the treatment of social anxiety disorder. The present study sought to establish whether, during community psychopharmacological treatment of social anxiety disorder, changes in positive or negative affect and agreeable or quarrelsome behaviour mediate improvement in social anxiety symptom severity or follow from it. METHODS: Adults diagnosed with social anxiety disorder (n = 48) recorded their interpersonal behaviour and affect naturalistically in an event-contingent recording procedure for 1-week periods before and during the first 4 months of treatment with paroxetine. Participants and treating psychiatrists assessed the severity of social anxiety symptoms monthly. A multivariate latent change score framework examined temporally lagged associations of change in affect and interpersonal behaviour with change in social anxiety symptom severity. RESULTS: Elevated agreeable behaviour and positive affect predicted greater subsequent reduction in social anxiety symptom severity over the following month of treatment. Elevated negative affect, but not quarrelsome behaviour, predicted less subsequent reduction in symptom severity. LIMITATIONS: Limitations included limited assessment of extreme behaviour (e.g., violence) that may have precluded examining the efficacy of paroxetine because of the lack of a placebo control group. CONCLUSION: The present study suggests that interpersonal behaviour and affect may be putative mechanisms of action for serotonergic treatment of social anxiety disorder. Prosocial behaviour and positive affect increase during serotonergic treatment of social anxiety disorder. Specifically, modulating agreeable behaviour, positive affect and negative affect in individuals’ daily lives may partially explain and refine clinical intervention. Joule Inc. 2021-01 /pmc/articles/PMC7955850/ /pubmed/33026311 http://dx.doi.org/10.1503/jpn.190164 Text en © 2021 Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is non-commercial (i.e. research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research Paper
Rappaport, Lance M.
Hunter, Michael D.
Russell, Jennifer J.
Pinard, Gilbert
Bleau, Pierre
Moskowitz, D.S.
Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title_full Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title_fullStr Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title_full_unstemmed Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title_short Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder
title_sort emotional and interpersonal mechanisms in community ssri treatment of social anxiety disorder
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955850/
https://www.ncbi.nlm.nih.gov/pubmed/33026311
http://dx.doi.org/10.1503/jpn.190164
work_keys_str_mv AT rappaportlancem emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder
AT huntermichaeld emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder
AT russelljenniferj emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder
AT pinardgilbert emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder
AT bleaupierre emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder
AT moskowitzds emotionalandinterpersonalmechanismsincommunityssritreatmentofsocialanxietydisorder